Many types of cancer are caused by gene mutations acquired during a person’s lifetime. Systematic cataloging of these acquired gene defects has led to improved screening, detection, diagnosis, prevention and treatment. A more deliberate investment in discovery research could reveal more opportunities for developing cancer treatment by making better sense of the acquired gene defects(...)
cancer research
Top Maryland scientists discuss research on tracking and treating cancer
Posted by | ResearchAt the annual Research Matters conference yesterday, top scientists from the Johns Hopkins Kimmel Cancer Center and University of Maryland Greenebaum Cancer Center discussed research using advanced imaging methods to develop better ways pinpoint and track cancer cells — down to the microscopic level — and precisely target each cell with anti-cancer drugs. Experts also delivered presentations(...)
A Conversation about Cancer: Six Questions that Keep Cancer Experts Up at Night
Posted by | Research, UncategorizedWhat keeps you up at night? This was the question posed by Kimmel Cancer Center director William Nelson, M.D., Ph.D., to six cancer experts who participated in a Cancer Conversations forum on Nov. 3, 2015. In parts one and two of this series, they predicted the future of cancer medicine and discussed how they collaborate(...)
A Conversation about Cancer: How We Collaborate
Posted by | Research, UncategorizedIn part one of this series, experts at the Johns Hopkins Kimmel Cancer Center discussed their predictions for the future of cancer medicine during a Cancer Conversations forum on Nov. 3, 2015. These experts also discussed how they collaborate with other scientists. On the panel were: Kimmel Professor and Director of Radiation Oncology and Molecular(...)
A Conversation about Cancer
Posted by | precision medicine, Prevention/Screening, Research, UncategorizedOn Nov. 3, 2015, a capacity crowd of more than 250 Johns Hopkins leaders, faculty, staff, students, donors, and other guests filled the Albert H. Owens Auditorium at the Johns Hopkins Kimmel Cancer Center to honor the philanthropy of Sidney Kimmel for advancing cancer discovery and care. Hundreds more watched via video streaming as Kimmel(...)
Boost to Cancer Research with Half Billion Gift from Ludwig Fund
Posted by | Research2014 is off to a great start. Johns Hopkins is one of six centers to share in a half billion-gift to cancer research. Our center will receive about $90 million in new funding, which will outlast the current directors of the Ludwig Center at Johns Hopkins and fund new generations of cancer scientists until we beat(...)
Clinical Trials Q and A: What is a clinical trial?
Posted by | ResearchWe’re starting a series on frequently asked questions about Kimmel Cancer Center clinical trials. This first question is the most basic: What is a clinical trial? A clinical trial is research study that involves people to test new ways of preventing, diagnosing or treating cancer. While many patients think that all clinical trials test experimental(...)
Collaboration: The Key to a Cancer Cure
Posted by | Research--This post is written by Kerri Kaplan, executive director of The Lustgarten Foundation I’m often asked about new developments in the research landscape of pancreatic cancer, the nation’s most lethal cancer. As executive director of The Lustgarten Foundation, the nation’s largest non-profit foundation dedicated to funding pancreatic cancer research, I have seen tremendous progress made(...)
Gene Patents Get Supreme Decision
Posted by | precision medicineLast week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns Hopkins experts had to say about the topic: "I am thrilled with the Supreme Court's unanimous decision to overturn gene patents. This was the only choice and will open up(...)
Creativity Competition Creates New Ideas to Cure Cancer
Posted by | ResearchLast Friday, the historic Hurd Hall at Johns Hopkins was filled to capacity with students, faculty and staff waiting to hear five scientists – all in the early part of their careers – describe their novel ideas on how to cure metastatic cancer. It was part of a competition on creative thinking named for John(...)
1 2